Form 4: Integra LifeSciences Director Raymond G. Murphy Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Raymond G. Murphy reports acquisition and disposal of Integra LifeSciences Holdings Corp (IART) common stock.
Summary
- On May 9, 2024, Raymond G. Murphy, a director of Integra LifeSciences Holdings Corp, reported changes in beneficial ownership of the company's common stock.
- Murphy acquired 8,696 shares of common stock at $0.
- Following the transaction, Murphy directly owns 54,007 shares of common stock.
- Murphy indirectly owns 28,761 shares through a spouse.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard reporting of stock transactions by a company director.
Industry Context
Form 4 filings are standard practice for company insiders (directors, officers, and major shareholders) to report transactions in their company's stock, providing transparency to the market.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the trading activities of a company insider.
Key Dates
| Date | Description |
|---|---|
| 05/09/2024 | Date of transaction involving common stock. |
| 05/13/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.